Cargando…
Reduced Expression of Deubiquitinase USP33 Is Associated with Tumor Progression and Poor Prognosis of Gastric Adenocarcinoma
BACKGROUND: Ubiquitin-specific peptidase 33 (USP33) is a deubiquitinase that balances the ubiquitin status of proteins. It has been reported to act as a tumor suppressor in colorectal cancer and lung cancer. However, the expression pattern and clinical significance of USP33 have not been investigate...
Autores principales: | Chen, Yan, Pang, Xumei, Ji, Lijuan, Sun, Yingchun, Ji, Yongjing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996837/ https://www.ncbi.nlm.nih.gov/pubmed/29802710 http://dx.doi.org/10.12659/MSM.908075 |
Ejemplares similares
-
The Deubiquitinase USP17 Regulates the Stability and Nuclear Function of IL-33
por: Ni, Yingmeng, et al.
Publicado: (2015) -
Deubiquitinases USP20/33 promote the biogenesis of tail-anchored membrane proteins
por: Culver, Jacob A., et al.
Publicado: (2021) -
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma
por: Pérez-Mancera, Pedro A., et al.
Publicado: (2012) -
Increased Expression of Serine Hydroxymethyltransferase 2 (SHMT2) is a Negative Prognostic Marker in Patients with Hepatocellular Carcinoma and is Associated with Proliferation of HepG2 Cells
por: Ji, Lijuan, et al.
Publicado: (2019) -
Targeting deubiquitinase USP28 for cancer therapy
por: Wang, Xiaofang, et al.
Publicado: (2018)